Archives: GVB release
PRINEVILLE, Ore., Jan. 3, 2024 — GVB Biopharma, a pioneer in the hemp and cannabis industry, is thrilled to announce its transition back to a private entity controlled by its founding team as of December 28th, 2023. Acquired by NASDAQ listed 22nd Century Group in May 2022, this strategic move marks a new chapter in GVB’s story. As […]
LONDON, UK, April 7, 2022 – GVB Biopharma, a biopharmaceutical company specializing in hemp and cannabis-related white-label consumer products, announced today that all of its products remain approved by the Food Standards Agency (FSA) after the organization created stricter market standards for foods containing cannabidiol (CBD) sold in most United Kingdom (UK) countries. On April 1, […]
LAS VEGAS, March 30, 2022 — GVB Biopharma, a biopharmaceutical company specializing in hemp and cannabis-related white-label consumer products, announced today that its website has launched sales of cannabigerolic acid isolates, popularly known as CBGa. CBGa is the carboxylic acid form of cannabigerol, known as CBG. It is a precursor molecule to delta-9-tetrahydrocannabinol, one of […]
LAS VEGAS, March 21, 2022 — With validation of its Novel Food application to the FSA, GVB Biopharma continues to strengthen its UK and European activities. GVB is one of the largest US CBD manufacturers and has several modern production facilities. GVB is one of the few true “seed to shelf” suppliers remaining in this space. GVB […]
GRASS VALLEY, Ore., Feb. 1, 2022 — GVB Biopharma, a biopharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it is experiencing a sizable increase in interest and orders for cannabidiolic acid, a cannabinoid popularly known as CBDa. Since the first month that CBDa sales began at GVB, internal data shows that the […]
NEW YORK, Oct. 20, 2021 — GVB Biopharma, the leader in hemp-derived cannabinoid active ingredient production and white label product formulation, announced today that it has been named Leading Manufacturer of the Year at the 2021 New York City White Label Expo. The event, held annually in the fall, acts as a premier showcase and sourcing show […]
LAS VEGAS, Jan. 12, 2021 — Certification from Major USDA-Accredited Organic Certifier Sets GVB Biopharma Apart from Competition. GVB Biopharma, the leader in hemp-derived cannabinoid active ingredient production and white label product formulation, has received Handling certification from USDA-accredited certifier California Certified Organic Farmers (CCOF). Effective December 22nd, 2020, this prestigious certification does not have an expiration […]
BOCA RATON, Fla., Oct. 13, 2020 — GVB Biopharma, a nutraceutical company specializing in hemp and cannabis-related consumer products, announced today that it has opened its fourth national sales and business development office in Boca Raton, FL. The Boca Raton office is GVB’s third new sales office opened this year, joining its sister offices in Los Angeles, Chicago and Denver. Along with state-of-the-art facilities for […]
LAS VEGAS, Aug. 6, 2020 — GVB Biopharma, a pharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it has established the process and infrastructure for producing medicinal products from cannabigerol (CBG). With this venture, GVB Biopharma creates a scientific foundation and professional network for a research and development program for CBG, allowing for […]
LAS VEGAS, Jan. 21, 2020 — GVB Biopharma, an industrial hemp company specializing in cannabinoid-based consumer products, is showcasing its 40,000 square-foot Las Vegas product manufacturing facility. Consistent with GVB Biopharma’s principled approach to ensuring quality in its consumer products, this state-of-the-art facility carries all proper licensing and operates in full compliance with all applicable regulatory requirements. “Between our central Oregon and Las […]